Cargando…
Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
The prevalence of coronary artery disease (CAD) in patients with severe aortic stenosis (AS) is 30–68%. Nevertheless, there is still not enough evidence to use invasive assessment of lesion severity, because the hemodynamic milieu of AS may impact the fractional flow reserve (FFR) and non-hyperemic...
Autores principales: | Dobrolinska, M. M., Gąsior, P., Błach, A., Gocoł, R., Hudziak, D., Wojakowski, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775333/ https://www.ncbi.nlm.nih.gov/pubmed/36546930 http://dx.doi.org/10.3390/biomimetics7040230 |
Ejemplares similares
-
Conscious sedation and local anesthesia for transcarotid transcatheter aortic valve implantation: Why not?
por: Hudziak, Damian, et al.
Publicado: (2021) -
Short-term safety and efficacy of transcarotid transcatheter aortic valve implantation with balloon-expandable vs. self-expandable valves
por: Hudziak, Damian, et al.
Publicado: (2021) -
Comparison of transcarotid versus transapical transcatheter aortic valve implantation outcomes in patients with severe aortic stenosis and contraindications for transfemoral access
por: Hudziak, Damian, et al.
Publicado: (2023) -
Transcatheter transapical valve-in-valve implantation for degenerated mitral bioprosthesis
por: Lelek, Michał, et al.
Publicado: (2017) -
Transcatheter aortic valve implantation in moderate bicuspid aortic valve disease in a patient with end-stage dilated cardiomyopathy – bridge to heart transplantation
por: Mizia-Szubryt, Magdalena, et al.
Publicado: (2021)